THE INVESTOR

메뉴열기

Hanmi Pharma to begin overseas sales of medication management solutions

PUBLISHED : August 31, 2017 - 17:06

UPDATED : August 31, 2017 - 17:06

  • 본문폰트 작게
  • 본문폰트 크게
  • 페이스북
  • 트위터
  • sms

[THE INVESTOR] Hanmi Pharmaceutical said on Aug. 31 it will commence overseas operations of its medication management automation affiliate JVM from September.

“As JVM is ready for mass production, we will aggressively launch overseas business in the US and Europe using its network,” the drug maker said in a press release. 




Hanmi Science, holding company of the pharmaceutical firm, acquired a 30 percent stake in JVM for 129.1 billion won (US$114.7 million) in June last year.

With the merger agreement, Hanmi has been in charge of sales while JVM has focused on production and development.

JVM, which logged sales of 98.1 billion won in 2016, is among the world’s top four firms in the automated pharma management business, with over 200 patented technologies. The company produces an automatic medication inspection system and tablet packaging system which provides accurate drug administration and real-time track and traceability.

By Park Han-na (hnpark@heraldcorp.com)

  • 페이스북
  • 트위터
  • sms
최상단으로
Herald Corporation|CEO : Kwon Chung Won
JUVENILE PROTECTION MANAGER : Shin Chang Hoon
Company Registration No. 104-81-06004
Mail-Order Business Registration 2016 - Seoul Yongsan - 00590
Huam-ro 4-gil 10, Yongsan-gu, Seoul, Korea
T : +82-2-727-0615|Business info
COPYRIGHT HERALD CORPORATION. ALL RIGHTS RESERVED.